Research released by the clinical AI company shows that its dose verification tool outperformed general-use AI models, which it says are rife with errors. It’s Doximity’s latest play to stand out as major AI companies forge into healthcare.
Research released by the clinical AI company shows that its dose verification tool outperformed general-use AI models, which it says are rife with errors. It’s Doximity’s latest play to stand out as major AI companies forge into healthcare.